Cargando…
Optimal Management of Patients with Advanced or Metastatic Cholangiocarcinoma: An Evidence-Based Review
Cholangiocarcinomas are rare tumors originating at any point along the biliary tree. These tumors often pose significant challenges for diagnosis and treatment, and often carry a poor prognosis. However, in recent years, studies have identified significant molecular heterogeneity with up to 50% of t...
Autores principales: | Ioffe, Dina, Phull, Pooja, Dotan, Efrat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558827/ https://www.ncbi.nlm.nih.gov/pubmed/34737637 http://dx.doi.org/10.2147/CMAR.S276104 |
Ejemplares similares
-
Management of Locally Advanced or Metastatic Combined Hepatocellular Cholangiocarcinoma
por: Zhao, Jemmy, et al.
Publicado: (2023) -
Advances in the management of cholangiocarcinoma
por: Zori, Andreas G, et al.
Publicado: (2021) -
Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma
por: Fostea, Raluca Maria, et al.
Publicado: (2020) -
Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib
por: Yu, James, et al.
Publicado: (2021) -
Dosing Schedules of Gemcitabine and nab-Paclitaxel for Older Adults With Metastatic Pancreatic Cancer
por: Winer, Arthur, et al.
Publicado: (2021)